What is a stock summary page? Click here for an overview.
Business Description
Spruce Biosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US85209E1091
Share Class Description:
SPRB: Ordinary SharesDescription
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.59 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.21 | |||||
| Beneish M-Score | -1.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 36.9 | |||||
| 3-Year FCF Growth Rate | 42.8 | |||||
| 3-Year Book Growth Rate | -33.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 21.55 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.09 | |||||
| 9-Day RSI | 24.7 | |||||
| 14-Day RSI | 28.94 | |||||
| 3-1 Month Momentum % | -12.71 | |||||
| 6-1 Month Momentum % | -13.5 | |||||
| 12-1 Month Momentum % | -48.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.36 | |||||
| Quick Ratio | 5.36 | |||||
| Cash Ratio | 5.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.8 | |||||
| Shareholder Yield % | 13.66 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -608.94 | |||||
| Net Margin % | -555.23 | |||||
| FCF Margin % | -654.78 | |||||
| ROE % | -58.1 | |||||
| ROA % | -44.29 | |||||
| ROIC % | -464.77 | |||||
| 3-Year ROIIC % | -428.08 | |||||
| ROC (Joel Greenblatt) % | -3488.39 | |||||
| ROCE % | -55.51 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.82 | |||||
| PB Ratio | 0.25 | |||||
| Price-to-Tangible-Book | 0.25 | |||||
| EV-to-EBIT | 1.12 | |||||
| EV-to-Forward-EBIT | -0.42 | |||||
| EV-to-EBITDA | 1.12 | |||||
| EV-to-Forward-EBITDA | -0.42 | |||||
| EV-to-Revenue | -6.15 | |||||
| EV-to-Forward-Revenue | 16.98 | |||||
| EV-to-FCF | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 0.26 | |||||
| Price-to-Net-Cash | 0.28 | |||||
| Earnings Yield (Greenblatt) % | 89.29 | |||||
| FCF Yield % | -354.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SPRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spruce Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7.101 | ||
| EPS (TTM) ($) | -0.94 | ||
| Beta | 2.15 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.39 | ||
| Volatility % | 89.53 | ||
| 14-Day RSI | 28.94 | ||
| 14-Day ATR ($) | 0.023179 | ||
| 20-Day SMA ($) | 0.34159 | ||
| 12-1 Month Momentum % | -48.39 | ||
| 52-Week Range ($) | 0.3044 - 0.87 | ||
| Shares Outstanding (Mil) | 41.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spruce Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spruce Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spruce Biosciences Inc Frequently Asked Questions
What is Spruce Biosciences Inc(SPRB)'s stock price today?
The current price of SPRB is $0.32. The 52 week high of SPRB is $0.87 and 52 week low is $0.30.
When is next earnings date of Spruce Biosciences Inc(SPRB)?
The next earnings date of Spruce Biosciences Inc(SPRB) is 2025-03-27 Est..
Does Spruce Biosciences Inc(SPRB) pay dividends? If so, how much?
Spruce Biosciences Inc(SPRB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers